Gastal mint pills №12

Composition

One pill contains: active substances: aluminum hydroxide-magnesium carbonate gel 450.0 mg, Magnesium hydroxide 300.0 mg; Excipients: mannitol (E421) 120.0 mg, sorbitol (E420) 50.00 mg, lactose monohydrate 30.00 mg, starch cucursum 75.80 mg, sodium cyclamate 7.00 mg, sodium saccharinate 0.20 mg, talc 28.00 mg, magnesium stearate 6.00 mg, peppermint flavor 3.00 mg.

Drug Gastal^® - combined antacid, which reduces the increased acidity of gastric juice and has no stimulating effect on the secretion of gastric juice. Aluminum hydroxide-magnesium carbonate gel and magnesium hydroxide provide immediate (immediately after ingestion) and prolonged (about 2 hours) neutralization of the hydrochloric acid of the gastric juice, while maintaining the acidity in the stomach at a physiological level (pH 3-5). One pill Gastal^® neutralizes 21.5 mmol of hydrochloric acid.

Drug Gastal^® inhibits the action of penzina, lysolecithin and bile acids, eliminates dyspeptic phenomena. Strengthens protective and regenerative processes in the mucous membrane of the stomach. Aluminum ions have a cytoprotective effect due to increased secretion of mucin and sodium bicarbonate, activation of prostaglandin E2 and N0, accumulation of epidermal growth factor at the site of damage to the mucous membrane, increasing the concentration of phospholipids in the walls of the stomach.

Drug Gastal^® does not have a systemic effect in patients with normal renal function. After interacting with the hydrochloric acid of gastric aluminum juice, the hydroxide reacts with the phosphate and carbonates in the alkaline medium of the intestine and is excreted in the form of insoluble salts. Magnesium hydroxide reacts with hydrochloric acid in the gastric juice to form magnesium chloride, which has osmotic properties and a mild laxative effect that neutralizes the fixative effect of aluminum hydroxide in the small intestine. Magnesium ions are excreted in the form of insoluble carbonate.

Indications and usage

- Dyspeptic symptoms, such as discomfort or pain in the epigastrium, heartburn, acid regurgitation after errors in the diet, excessive use of ethanol, coffee, nicotine, etc.;

- dyspeptic symptoms, such as discomfort or pain in the epigastrium, heartburn, acid regurgitation (and their prevention), resulting from the use of certain drugs (nonsteroidal anti-inflammatory drugs, glucocorticosteroids, etc.);

- conditions accompanied by increased acid formation: gastric ulcer, gastritis, reflux esophagitis; hiatal hernia.

Contraindications

Hypersensitivity to salts of aluminum, magnesium or other components of the drug; severe renal failure; Alzheimer's disease; hypophosphatemia; lactose intolerance, lactase deficiency or glucose-galactose malabsorption; children's age up to 6 years.

In chronic renal failure (CRF), pregnancy and during breastfeeding, adults and children over 12 years old with a body weight less than 50 kg, children from 6 to 12 years old, old age.

Pregnancy and Breastfeeding

Drug Gastal^® not excreted in breast milk. When used during pregnancy and during breastfeeding, it is necessary to assess the ratio of benefits to the mother and the risk to the fetus and baby.

Inside, gradually dissolving in the mouth.

Adults and children over 12 years old with a body weight of at least 50 kg

1-2 pills 4-6 times a day approximately 1 hour after meals and at bedtime, but not more than 8 pills per day. The duration of treatment is not more than 2 weeks. Similar doses are recommended for the treatment of heartburn, regardless of the meal.

Adults and children over 12 years old weighing less than 50 kg, children aged 6 to 12 years

The dose is half the recommended dose for adults and children over 12 years old with a body weight of at least 50 kg. The duration of treatment is not more than 2 weeks.

Patients with PCN

Dose adjustment is not required. The duration of treatment is not more than 2 weeks.

Overdosage

Symptoms of acute overdose are not described.

With prolonged use of high doses of drugs containing aluminum and magnesium, hypophosphatemia, hypocalcemia, hypercalciuria, osteomalacia, osteoporosis, hypermagnemia, hyperaluminemia, encephalopathy, nephrocalcinosis and impaired renal function may develop.Perhaps the development of more pronounced adverse reactions from the gastrointestinal tract (GIT) (constipation, diarrhea), in patients with renal insufficiency - thirst, lower blood pressure, hyperoflexion.

Treatment: symptomatic therapy.

Adverse reactions

When using the drug in recommended doses, adverse reactions are rare (at least 0.01%, but less than 0.1%): nausea, constipation, diarrhea, change in taste. In exceptional cases, allergic reactions are possible.

Drug interactions

Drug Gastal^® while the use of levodopa and enhances the activity of nalidixic acid and reduces delays absorption quinolones, isoniazid, Naproxen, iron preparations, Indomethacin, chlorpromazine, beta-blockers, diflunisal, H2-blockers gistominovyh receptors of fat-soluble Vitamins, anticoagulants, barbiturates.

When interacting with the metal ions that make up the antacids, tetracyclines form insoluble chelate complexes; As a result of this interaction, the absorption of tetracyclines is reduced by more than 90%. Simultaneous administration of these drugs is not possible. If necessary, combined use, Tetracycline should be taken at least 2 hours before taking an antacid.

In the presence of aluminum and magnesium hydroxides contained in the antacid, the absorption of Ciprofloxacin and Ofloxacin is reduced by 50-90%.

In the presence of antacids, bioavailability of Captopril is significantly reduced, and the combined use of antacids and Metoprolol leads to a decrease in plasma plasma concentration of metoprolol.

The simultaneous use of high doses of antacids can reduce the absorption of Ranitidine by 10-33%.

The use of antacids does not affect the bioavailability of Amoxicillin, tsevalexin and the combination of amoxicillin and clavulanic acid, but it can significantly reduce the absorption of Doxycycline from the gastrointestinal tract.

An increase in urine pH during antacid therapy may enhance the tubular reabsorption of essential (alkaline) drugs and reduce the reabsorption of acidic compounds. Antacids can reduce and slow down the absorption of salicylates, including Acetylsalicylic acid, as well as increasing the urine pH, promote more rapid elimination of salicylates from the body, with a concomitant decrease in their concentration in serum by 30-70%.

The absorption of cardiac glycosides, including Digoxin and digitoxin, with simultaneous use with antacids is not significantly reduced. M-holinoblokatory, slowing down the motility of the stomach, increase the duration of the drug Gastal^®.

In order to prevent possible interaction of the drug Gastal^® with other drugs it is recommended to take it 1 hour before or 1 hour after their use.

Special notes

Do not exceed the recommended dose and duration of treatment when used in patients with impaired renal function.

Influence on ability at management of transport and work with equipment

Use of the drug Gastal^® does not affect the ability to drive motor vehicles and control other mechanisms.

Storage conditions

Store at a temperature not higher than 25 ° С.

Keep out of the reach of children.